Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03330054
Other study ID # AssiutU MRAbdallah
Secondary ID
Status Not yet recruiting
Phase N/A
First received October 31, 2017
Last updated November 4, 2017
Start date December 1, 2017
Est. completion date June 1, 2018

Study information

Verified date November 2017
Source Assiut University
Contact Mohamed R Abdallah
Phone 00201011770935
Email drmramadanas33@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study evaluate the frequency and type of eye problem among Type 2 Diabetics with renal impairment and effect of renal impairment and haemodialysis on diabetic retinopathy


Description:

Chronic kidney disease is a descriptive term and is used for deteriorating kidney function of any underlying cause. Chronic kidney disease implies longstanding (>3 months), potentially progressive, impairment in renal function.(Kumar & Clark's ., 2016).

Diabetes mellitus is the most common cause of chronic kidney disease in developed countries. In patients with diabetes, there is a steady advance from microalbuminuria to dipstick positive proteinuria and a progression to renal failure. (Davidson's.,2014) .The most commonly diagnosed diabetes-related complications is diabetic retinopathy. Its prevalence increases with the duration of diabetes. Some 20%of people with type 1 diabetes will have retinal changes after 10 years, rising to >95% after20 years; 20-30% of people with type 2 diabetes have retinopathy at diagnosis.(Kumar & Clark's ., 2016) .

Also from risk factors of diabetic retinopathy is nephropathy, and if severe, is associated with worsening of Diabetic retinopathy. Conversely, treatment of renal disease (e.g. renal transplantation) may be associated with improvement of retinopathy and a better response to photocoagulation.(Kanaski ,2016) The high burden of ocular disease in Chronic kidney disease can be explained, in part, by the sharing of risk factors common to both kidney and eye diseases such as age, smoking, hypertension, diabetes, raised serum cholesterol and obesity. Ocular diseases may also be directly linked to chronic kidney disease via common pathogenic pathways, including, atherosclerosis, microangiopathy, inflammation and oxidative stress (Wong et al., 2014).

In our study we seek to do the following for participants :

1. A detailed history including

1. Age, sex, smoking Habits

2. Duration of diabetes mellitus and treatment.

3. Chronic kidney disease stage by estimated glomerular filtration rate according to MDRD formula

4. Duration of haemodialysis.

5. Associated co-morbidity as hypertension,

6. Therapeutic history eg; angiotensin converting enzyme, angiotensin II receptor blocker, amiodarone, erythropoietin.

2. Complete Clinical examination including haemodynamics, complete cardiac, chest, abdominal, lower limb examination, cranial nerve examination.

3. Complete eye examination including detailed fundus examination, classifying expected eye problems as:

- Cataract. - Glaucoma

- Cranial nerve affection

- Retinopathy either proliferative, non proliferative or macular oedema.

4. The following investigations will be done:

- Serum creatinine & Blood Urea for estimation of glomerular filtration rate

- Glycated haemoglobin (HbA1c).

- lipogram.

- Complete blood count

- ECG


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date June 1, 2018
Est. primary completion date May 1, 2018
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- 50 patients Type 2 Diabetes without renal impairment.

- 25 patients Type 2 Diabetes with chronic kidney disease not on replacement therapy. (stage I-IV)

- 25 patients Type 2 Diabetes with end-stage renal disease on haemodialysis

Exclusion Criteria:

- patients with previous history of eye problems and any systemic disease.

- Type 1 Diabetics .

- Acute kidney injury in Diabetics.

Study Design


Intervention

Device:
fundoscope
Fundoscope for eye examination

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Mohammed Ramadan Abdallah Assiut University

Outcome

Type Measure Description Time frame Safety issue
Primary Frequency Of Eye problems In Type 2 Diabetes with Chronic Kidney Disease To evaluate the frequency and type of eye problem among:
Type 2 Diabetics not having renal impairment.
Type 2 Diabetics with chronic kidney disease not on replacement therapy.
Type 2 Diabetics with end stage renal disease on haemodialysis.
2 days for each participant to be assessed
See also
  Status Clinical Trial Phase
Recruiting NCT03239366 - A Study to Evaluate the Effect of BioK+ 50B® on Glycemic Control in a Type 2 Diabetes Population Phase 2
Completed NCT04597229 - Efficacy of Multigrain Supplementation in Type II Diabetes Mellitus N/A
Completed NCT03623139 - Effects of Basic Carbohydrate Counting Versus Standard Outpatient Nutritional Education in Type 2 Diabetes N/A
Active, not recruiting NCT04599920 - Effects of Replacing Red Meat With Legumes on Biomarkers of Chronic Diseases in Healthy Men (Leg4Life) N/A
Active, not recruiting NCT03422471 - Hypoglycemia and Autonomic Nervous System Function- B2 N/A
Completed NCT04382521 - A Text Message Intervention to Promote Health Behaviors in Cardiac Risk Conditions N/A
Recruiting NCT04564391 - Whey or Casein - Liver Fat Reduction and Metabolic Improvement by Fast vs. Slow Proteins N/A
Recruiting NCT03458715 - The Efficacy of Sodium-glucose Co-transporter 2 Inhibitor or Dipeptidyl Peptidase-4 Inhibitor in Type 2 Diabetes Patients With Premix Insulin Phase 4
Terminated NCT03278236 - Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men? N/A
Completed NCT02974504 - Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN) Phase 4
Completed NCT05053828 - Type 2 Diabetes With Antiplatelet Drugs
Not yet recruiting NCT03659383 - The Exploration of Optimal Treatment Scheme in Patients With Type 2 Diabetes Inadequately Controlled With Glargine Phase 4
Completed NCT03542240 - Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic Syndrome N/A
Completed NCT03657537 - Effects of Ketone Bodies on Cognition in Type 2 Diabetes Phase 1
Completed NCT03979768 - Risk Assessment of Type 2 Diabetes in Pharmacies N/A
Completed NCT03614039 - Effect of Probiotic and Smectite Gel on NAFLD N/A
Active, not recruiting NCT04994288 - A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients Phase 2/Phase 3
Completed NCT03290768 - Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics - (Protocol 3) N/A
Enrolling by invitation NCT04088851 - "The Role of the Liver for Interorgan Metabolic Crosstalk in Type 2 Diabetes" N/A
Completed NCT03643783 - Impact of Plasma Soluble Prorenin Receptor in Obese and Type 2 Diabetic Patients